Suppr超能文献

PPARγ激动剂对HT-22细胞氧化损伤的神经保护作用。

Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.

作者信息

Aoun Paul, Watson David G, Simpkins James W

机构信息

Department of Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107-2699, USA.

出版信息

Eur J Pharmacol. 2003 Jul 4;472(1-2):65-71. doi: 10.1016/s0014-2999(03)01867-3.

Abstract

Peroxisome proliferator-activated receptors (PPARs) are involved in regulating many metabolic and inflammatory processes. The present study explores the role of PPAR ligands in protecting neuronal cultures from toxic insults. For that purpose, we used WY14643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid] as a PPARalpha agonist, L-165041 and L-783483 as PPARbeta ligands, and 15-deoxy-Delta(12,14)-PGJ2 (15d-PGJ2), troglitazone, and ciglitazone for PPARgamma. Experiments were performed using HT-22, an immortalized mouse hippocampal cell line, and SK-N-SH, a human neuroblastoma cell line. Cell viability against glutamate, hydrogen peroxide (H(2)O(2)), and serum deprivation insults was determined using a calcein acetoxymethyl (AM) assay. Of the compounds tested, only 15d-PGJ2 and troglitazone showed a dose-dependent neuroprotection from glutamate and H(2)O(2) insults in HT-22 cells. None of the PPAR agonists was protective in SK-N-SH cells. A minimum of 4-6 h preincubation with 15d-PGJ2 was required to achieve significant neuroprotection. On the other hand, troglitazone was protective even when administered simultaneously with glutamate, or for up to 8 h postglutamate insult. To investigate whether the neuroprotective effects are mediated through PPARgamma, we first determined through Western blotting that HT-22 and SK-N-SH cells express PPARgamma. However, the neuroprotective effects of those compounds are unlikely to be mediated through the PPARgamma for two reasons: (1) various concentrations of another PPARgamma agonist (ciglitazone) were not neuroprotective; (2) by itself, PPAR exhibits a low affinity for DNA, and high-affinity binding requires heterodimerization with RXR, the 9-cis-retinoic acid receptor; administering 9-cis-retinoic acid in conjunction with 15d-PGJ2 did not alter the neuroprotective effects of the latter. Our results demonstrate neuroprotective effects of 15d-PGJ2 and troglitazone that are likely independent of PPARgamma.

摘要

过氧化物酶体增殖物激活受体(PPARs)参与调节多种代谢和炎症过程。本研究探讨了PPAR配体在保护神经元培养物免受毒性损伤中的作用。为此,我们使用WY14643 [4-氯-6-(2,3-二甲基苯胺基)-2-嘧啶硫代乙酸]作为PPARα激动剂,L-165041和L-783483作为PPARβ配体,以及15-脱氧-Δ(12,14)-前列腺素J2(15d-PGJ2)、曲格列酮和吡格列酮作为PPARγ配体。实验使用永生化小鼠海马细胞系HT-22和人神经母细胞瘤细胞系SK-N-SH进行。使用钙黄绿素乙酰氧基甲酯(AM)测定法测定细胞对谷氨酸、过氧化氢(H₂O₂)和血清剥夺损伤的活力。在所测试的化合物中,只有15d-PGJ2和曲格列酮在HT-22细胞中对谷氨酸和H₂O₂损伤表现出剂量依赖性神经保护作用。在SK-N-SH细胞中,没有一种PPAR激动剂具有保护作用。与15d-PGJ2预孵育至少4 - 6小时才能实现显著的神经保护作用。另一方面,即使与谷氨酸同时给药,或在谷氨酸损伤后长达8小时给药,曲格列酮仍具有保护作用。为了研究神经保护作用是否通过PPARγ介导,我们首先通过蛋白质印迹法确定HT-22和SK-N-SH细胞表达PPARγ。然而,这些化合物的神经保护作用不太可能通过PPARγ介导,原因有两个:(1)不同浓度的另一种PPARγ激动剂(吡格列酮)没有神经保护作用;(2)PPAR本身对DNA的亲和力较低,高亲和力结合需要与9-顺式视黄酸受体RXR形成异二聚体;将9-顺式视黄酸与15d-PGJ2联合给药并没有改变后者的神经保护作用。我们的结果表明,15d-PGJ2和曲格列酮的神经保护作用可能独立于PPARγ。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验